Could always look at Kites BLA lodgement as a loose timeline case study if MSB given same path.CAR T Cell therapy
BLA lodged around Dec 12Granted Breakthrough Therapy StatusJust granted Priority Review status
Approx 60 days timeframe from lodge
https://www.trialsitenews.com/kite-pharma-submits-bla-to-fda-for-car-t-cell-therapy-kte-x19-for-r-r-mantle-cell-lymphoma/
https://lymphomanewstoday.com/2020/02/11/fda-priority-review-kite-car-t-cell-therapy-kte-x19-mcl-mantle-cell-lymphoma/
MSB Trading - 2020, page-2132
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
-0.210(11.8%) |
Mkt cap ! $1.792B | |||
| Open | High | Low | Value | Volume |
| $1.72 | $1.74 | $1.52 | $15.63M | 9.716M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5127 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.57 | 39613 | 3 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |